Gene · 6470
Papers1,819
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,819
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SHMT proteins: An emerging set of serine hydroxymethyltransferase in cancer. | Cell Signal | 2025 | 40617370 | PubTator, text mining | PubMed |
| RNA-binding proteins as versatile metabolic regulators. | NPJ Metab Health Dis | 2025 | 40603707 | PubTator, text mining | PubMed |
| Correlation analysis between clinical effective emotional treatment and plasma N-methyl-D-aspartate receptor function-related indexes. | Front Neurosci | 2025 | 40529247 | PubTator, text mining | PubMed |
| Glycine as a conditionally essential amino acid and its relationship to l-serine. | Metabolism | 2025 | 40527450 | PubTator, text mining | PubMed |
| miR-944 inhibits malignant progression of bladder cancer through ATIC/AKT/FOXO3 A axis mediated by SHMT1. | In Vitro Cell Dev Biol Anim | 2025 | 40442541 | PubTator, text mining | PubMed |
| Multi-Omics and -Organ Insights into Energy Metabolic Adaptations in Early Sepsis Onset. | Adv Sci (Weinh) | 2025 | 40411399 | PubTator, text mining | PubMed |
| Genome-wide enhancer-gene regulatory maps of liver reveal novel regulatory mechanisms underlying NAFLD pathogenesis. | BMC Genomics | 2025 | 40375105 | PubTator, text mining | PubMed |
| RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer. | Front Immunol | 2025 | 40370450 | PubTator, text mining | PubMed |
| SHMT inhibitor synergizes with 5-Fu to suppress gastric cancer via cell cycle arrest and chemoresistance alleviation. | NPJ Precis Oncol | 2025 | 40346149 | PubTator, text mining | PubMed |
| Studying sleep orthologs in Epsilonproteobacteria through an evolutionary lens: investigating sleep mysteries through phylogenomics. | World J Microbiol Biotechnol | 2025 | 40289222 | PubTator, text mining | PubMed |
| TFE3 and HIF1α regulates the expression of SHMT2 isoforms via alternative promoter utilization in ovarian cancer cells. | Cell Death Dis | 2025 | 40097394 | PubTator, text mining | PubMed |
| Identification and validation of diagnostic biomarkers for temporal lobe epilepsy related to ferroptosis and potential therapeutic targets. | Sci Rep | 2025 | 39930056 | PubTator, text mining | PubMed |
| The Inhibitory Effects of NCT503 and Exogenous Serine on High-Selenium Induced Insulin Resistance in Mice. | Nutrients | 2025 | 39861441 | PubTator, text mining | PubMed |
| Integrative bioinformatics approach identifies novel drug targets for hyperaldosteronism, with a focus on SHMT1 as a promising therapeutic candidate. | Sci Rep | 2025 | 39799159 | PubTator, text mining | PubMed |
| Activation of the De Novo Serine Synthesis Pathway and Disruption of Insulin Signaling Induced by Supplemental SeMet in Vitro. | Biol Trace Elem Res | 2025 | 39789350 | PubTator, text mining | PubMed |
| H4K20me3-Mediated Repression of Inflammatory Genes Is a Characteristic and Targetable Vulnerability of Persister Cancer Cells. | Cancer Res | 2025 | 39476057 | PubTator, text mining | PubMed |
| SHIN-2 exerts potent activity against VanA-type vancomycin-resistant Enterococcus faecium in vitro by stabilizing the active site loop of serine hydroxymethyltransferase. | Arch Biochem Biophys | 2024 | 39313141 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts derived fibronectin extra domain A promotes sorafenib resistance in hepatocellular carcinoma cells by activating SHMT1. | Genes Dis | 2024 | 39286657 | PubTator, text mining | PubMed |
| Universality of critical active site glutamate as an acid-base catalyst in serine hydroxymethyltransferase function. | Chem Sci | 2024 | 39148791 | PubTator, text mining | PubMed |
| Knockdown of ERN1 disturbs the expression of phosphoserine aminotransferase 1 and related genes in glioblastoma cells. | Arch Biochem Biophys | 2024 | 39059599 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6470/papers?page=4